Last reviewed: July 16, 2026 Last updated: July 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Lets see how it compares to other popular medications
Plaintiffs allege the development of serious gastrointestinal conditions, including gallbladder removal and gastroparesis, attributed to these medications
This creates a clear chain of accountability, linking the drug directly to the patient and the prescriber
Most patients begin noticing early improvements within the first one to two weeks, with the most meaningful results taking shape between weeks four and eight